3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Terminated
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Stomach Neoplasms
30
Carcinoma, Hepatocellular
22
Small Cell Lung Carcinoma
15
Colorectal Neoplasms
14
Carcinoma, Non-Small-Cell Lung
14
Sarcoma
13
Ovarian Neoplasms
12
Breast Neoplasms
12
Triple Negative Breast Neoplasms
9
Nasopharyngeal Carcinoma
9
Esophageal Squamous Cell Carcinoma
9
Cholangiocarcinoma
9
Biliary Tract Neoplasms
7
Squamous Cell Carcinoma of Head and Neck
6
Osteosarcoma
6
Lung Neoplasms
6
Pancreatic Neoplasms
5
Head and Neck Neoplasms
5
Esophageal Neoplasms
5
Uterine Cervical Neoplasms
4
Thyroid Neoplasms
4
Neoplasms
4
Melanoma
4
Solid Tumor
3
Recurrence
3
Neoplasm Metastasis
3
Liver Neoplasms
3
Glioma
3
Gastric Adenocarcinoma
3
Carcinoma, Adenoid Cystic
3
Interventions
Rituximab
5
Valganciclovir
3
Zidovudine
2
Methotrexate
2
Leucovorin
2
Doxorubicin
2
merphos
1
cc-486
1
avelumab
1
apatinib
1
Vincristine
1
Valacyclovir
1
Vaccines
1
Tomography, X-Ray Computed
1
Prednisone
1
Nivolumab
1
Kidney Transplantation
1
Interferons
1
Hydroxyurea
1
Granulocyte Colony-Stimulating Factor
1
Gemcitabine
1
Filgrastim
1
Etoposide
1
Echocardiography
1
EPOCH protocol
1
Docetaxel
1
Dexamethasone
1
Cyclophosphamide
1
Cisplatin
1
Caves
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 2
×
Epstein-Barr Virus Infections
×
apatinib
×
Clear all
NCT02874651
2022-01-11
ADVANCE
Sun Yat-sen University
Phase 2
Terminated
25 enrolled